Target Name: NUP210P2
NCBI ID: G100129929
Other Name(s): nucleoporin 210 pseudogene 2 | Nucleoporin 210 pseudogene 2

NUP210P2: A Potential Drug Target and Biomarker

NUP210P2 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is neuropilin-210-protein, and it is a member of the neuropilin family. This protein has been shown to play a role in various physiological processes in the body, including cell signaling, neurotransmitter release, and blood pressure regulation. As a result, NUP210P2 has potential as a drug target or biomarker.

The neuropilin family consists of several proteins that are involved in the regulation of neural stem cells and the development of neural circuits. NUP210P2 is a potent inhibitor of the neuropilin-1 gene, which encodes the protein Nup210. This inhibition causes NUP210P2 to accumulate in the brain, where it can interact with the neuropilin-1 protein and disrupt its normal function.

The neuropilin-1 protein is a key regulator of the neurotransmitter release that occurs in the brain. It plays a role in the production, processing, and release of neurotransmitters, including dopamine, serotonin, and endocannabinoids. The neuropilin-1 protein is also involved in the regulation of pain perception and anxiety.

The accumulation of NUP210P2 in the brain can lead to the disruption of neurotransmitter release and a variety of physiological problems, including anxiety, depression, and pain perception. Additionally, the neuropilin-1 protein is involved in the regulation of blood pressure, and the disruption of its function can lead to hypertension.

In conclusion, NUP210P2 is a potential drug target and biomarker due to its involvement in the regulation of neurotransmitter release and blood pressure. The inhibition of NUP210P2 has been shown to cause a variety of physiological problems, including the disruption of neurotransmitter release, anxiety, depression, and pain perception. Further research is needed to fully understand the potential of NUP210P2 as a drug target or biomarker.

Protein Name: Nucleoporin 210 Pseudogene 2

More Common Targets

NUP214 | NUP35 | NUP37 | NUP42 | NUP43 | NUP50 | NUP50-DT | NUP54 | NUP58 | NUP62 | NUP62CL | NUP85 | NUP88 | NUP93 | NUP98 | NUPR1 | NUPR2 | NUS1 | NUS1P1 | NUS1P3 | NUSAP1 | NUTF2 | NUTF2P4 | NUTM1 | NUTM2A | NUTM2A-AS1 | NUTM2B | NUTM2B-AS1 | NUTM2D | NUTM2E | NUTM2F | NUTM2G | NVL | NWD1 | NWD2 | NXF1 | NXF2 | NXF3 | NXF4 | NXF5 | NXN | NXNL1 | NXNL2 | NXPE1 | NXPE2 | NXPE3 | NXPE4 | NXPH1 | NXPH2 | NXPH3 | NXPH4 | NXT1 | NXT2 | NXTAR | NYAP1 | NYAP2 | NYNRIN | NYX | OACYLP | OAF | OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A | OBP2B | OBSCN | OBSCN-AS1 | OBSL1 | OC90 | OCA2 | OCEL1 | OCIAD1 | OCIAD2 | OCLM | OCLN | OCLNP1 | OCM | OCM2 | OCRL | OCSTAMP | ODAD1 | ODAD2 | ODAD3 | ODAD4 | ODAM | ODAPH | ODC1 | ODCP | ODF1 | ODF2 | ODF2L